UK markets open in 4 hours 51 minutes

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.2616+0.0028 (+1.08%)
At close: 04:00PM EDT
0.2654 +0.00 (+1.45%)
After hours: 07:48PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.33-0.31-1.27-1.06
Low estimate-0.36-0.35-1.39-1.28
High estimate-0.27-0.28-1.16-0.52
Year ago EPS-0.36-0.27-1.26-1.27
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate350k350k1.58M810k
Low estimateN/AN/A500kN/A
High estimate530k530k2.13M1.59M
Year ago sales458k370k1.56M1.58M
Sales growth (year/est)-23.60%-5.40%1.40%-48.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.42-0.32-0.31-0.26
Actual EPS-0.36-0.27-0.22-0.35
Difference0.060.050.09-0.09
Surprise %14.30%15.60%29.00%-34.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.33-0.31-1.27-1.06
7 days ago-0.33-0.31-1.27-1.06
30 days ago-0.32-0.28-1.21-0.93
60 days ago-0.26-0.25-1.01-1.11
90 days ago-0.26-0.26-1.08-1.17
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLYRAIndustrySector(s)S&P 500
Current qtr.8.30%N/AN/AN/A
Next qtr.-14.80%N/AN/AN/A
Current year-0.80%N/AN/AN/A
Next year16.50%N/AN/AN/A
Next 5 years (per annum)-1.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A